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Abstract
Men who have sex with men (MSM) and transgender women are disproportionately affected by 
HIV in Guatemala, yet little is known about their experiences with diagnosis, linkage to care, and 
retention. We conducted qualitative interviews with 26 MSM and transgender women living with 
HIV in Guatemala City. HIV diagnosis experiences changed over time with increasing 
asymptomatic testing at non-governmental organizations. Fear of the physical and social impacts 
of HIV delayed testing, acceptance of diagnosis, and linkage to HIV care. These fears were driven 
by layered stigma and discrimination due to non-normative gender expressions and/or sexual 
orientation. Retention-specific determinants included HIV clinic dynamics and limited 
employment opportunities. There is an urgent need to improve support systems for early testing 
and linkage to care and to expand employment opportunities. Stigma and discrimination must be 
addressed at the family, clinic and contextual levels to reduce fear of diagnosis and improve access 
to care.
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The biomedical discovery that early initiation of anti-retroviral treatment reduces 
transmission of the HIV virus, referred to as “treatment as prevention” (TasP), creates a new 
opportunity for HIV prevention.1 Men who have sex with men (MSM) and transgender 
women are disproportionately affected by HIV in Guatemala. Only recently have targeted 
HIV surveillance data been collected to document this disparity and inform programming. 
While national level HIV prevalence among adults is estimated to be less than 1.0%,2 the 
most recent prevalence estimate among MSM is 8.9% and transgender women 23.8%.3 
There is a need to assess how to operationalize TasP to the reality of key populations living 
with HIV in concentrated epidemics with limited resources.4
Early diagnosis is critical for optimizing the impact of TasP, as the earlier that people get 
diagnosed, the earlier they can commence HIV care and treatment. In the most recent 
integrated behavioral and biological survey in Guatemala, 59.2% of MSM and 45.1% of 
transgender women reported having had an HIV test in the last 12 months.3 However, 
between 2011 and 2013, MSM and transgender women represented less than 1% of the HIV 
tests conducted by the Ministry of Health, highlighting major gaps in government-sponsored 
testing for these key populations.5 In qualitative studies with MSM and transgender women 
in Guatemala City, the main barriers to HIV testing identified include fear, layered stigma 
and discrimination due to gender identity and/or sexual orientation and HIV, lack of social 
support, and lack of knowledge and access to HIV testing resources.6,7 One consequence of 
these barriers to testing is that many MSM and transgender women are diagnosed with 
advanced cases of HIV, which has negative implications for their health as well as the 
opportunity for timely implementation and effectiveness of TasP.
In addition to experiencing a disproportionate burden of HIV and delayed testing, MSM and 
transgender women across the world experience barriers to getting into HIV care and staying 
in care, which are also critical for achieving TasP.8,9,10 The first HIV diagnosis in Guatemala 
was made in 1984.11 Up until the late 1990s, ART was extremely hard to acquire in 
Guatemala. Through the late 1990s and early 2000s, access to medication improved, but the 
supply was still insufficient and inconsistent. During this time, most medication available in 
Guatemala was imported by a volunteer program that imported unused HIV medications 
from infectious disease clinics in the US and international donors, including Doctors 
Without Borders.12 Since the mid-2000s, ART is acquired through a combination of 
Guatemalan government funding and the Global Fund to fight AIDS, Tuberculosis and 
Malaria.11 There are currently 17 HIV treatment providing units in Guatemala, mostly in 
public sector facilities, where ART is provided free of charge. In Guatemala City, where this 
study took place, 3 large public HIV clinics provide ART and also serve as referral centers. 
While access to treatment has improved dramatically during the last, it is estimated that only 
35% of the 52,784 people living with HIV in Guatemala are engaged in HIV care, 31% 
receive ART, and 16% are virally suppressed (viral load <50copies/ml).13 As a comparison, 
in a recent analysis of the HIV care continuum among MSM diagnosed with HIV in the US, 
where MSM also experience a disproportionate burden of HIV, 77.5% of those diagnosed 
were linked to care, 50.9% were engaged in care, 49.5% were prescribed antiretroviral 
therapy (ART) and 42.0% were virally suppressed.14 The drop-off from diagnosis to viral 
suppression identified in these studies highlights the need for improved understanding of the 
continuum across settings to inform context-specific interventions that translate the 
Barrington et al. Page 2
J Health Care Poor Underserved. Author manuscript; available in PMC 2017 July 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
biomedical advances of TasP to the reality of HIV clinics in low-income and middle-income 
countries.
Understanding HIV outcomes among key populations such as MSM and transgender women 
requires a contextualized understanding of their daily lives and the social and structural 
determinants of their wellbeing. Non-normative gender identity and sexual orientations 
pathologized in Guatemalan society.15 Men who have sex with men MSM and transgender 
Guatemalans are consistently denied basic human rights and experience disproportionate 
levels of violence in an already extremely violent society.16 Violence against transgender 
women and general transphobia are rampant.15,16 In our previous research, we identified 
fear of discrimination related to sexual and gender identity and behaviors, lack of 
confidentiality, fear of HIV stigma and discrimination, and distrust of service providers as 
barriers to sexual health services for MSM and transgender women in Guatemala City.6 We 
also found that most MSM live with their families and within their home environments 
experience a combination of stigma related to gender, sexual orientation, and HIV, as well as 
support, which could have implications for staying in HIV care and adhering to treatment.17
Given the limited understanding on the experience of living with and managing HIV among 
MSM and transgender women in Guatemala, we conducted a qualitative, formative study. 
The purpose of this paper is to describe the factors that shape the timing or stage of 
diagnosis, process of linking to care, and retention experiences of MSM and transgender 
women living with HIV in Guatemala City.
Methods
Study design and sample
This formative, qualitative study was conducted to improve understanding of the HIV 
experience among MSM and transgender women to inform the design of intervention 
strategies to improve outcomes along the HIV continuum of care in Guatemala City. We 
conducted in-depth interviews using a semi-structured guide to explore experiences with 
diagnosis, linkage, and retention in care. Eligibility for MSM included being at least 18 
years old, having received a positive HIV diagnosis, having had sexual relations with a man 
in the last 12 months, and not being noticeably under the effects of alcohol or drugs to give 
consent. For transgender women, in addition to these criteria, another eligibility requirement 
was that they had been born biologically male but currently identified as a woman and/or 
transgender. Initial recruitment was led by referrals from key informants who worked with 
local community-based groups and introduced the study to MSM and transgender women 
living with HIV and peers from the MSM and transgender communities; subsequently, study 
participants also made referrals to potential participants. We monitored thematic saturation, 
or the identification of recurring themes related to the study questions during data collection, 
to determine the final sample size.
Data collection
The in-depth interview guides were designed to elicit participants’ HIV diagnosis and care 
stories using open-ended questions and probing. We developed the guide as a team using a 
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collaborative, iterative process. We drew on our past experiences conducting qualitative 
interviews with sexual and gender minority populations living with HIV to inform the way 
we elicited narratives while still responding to our concrete interests in obtaining 
information to inform program development. All interviews were conducted in Spanish by 
one of two Guatemalan researchers, one man and one woman, in locations of convenience to 
the participants. Both interviewers were trained psychologists and had experience with 
qualitative interviewing. One interviewer had also been an HIV counselor and the other had 
doctoral-level training in critical sociology. Interviews were audio-recorded and transcribed 
by either the interviewer or a trained transcriber. In total, 26 interviews were completed (15 
with MSM and 11 with transgender women); each participant was interviewed one time. 
While individuals were recruited as representing either MSM or transgender, their identities 
were more fluid and frequently crossed over between these two categories, as we have found 
in other qualitative research with these populations in Guatemala.17 We used the same 
interview guide for both populations, modifying pronouns based on the gender preference of 
each participant. All participants provided written consent. They were provided with 
compensation for their transportation costs upon completion of the interview. The study was 
reviewed and approved by the Institutional Review Boards at the University of North 
Carolina at Chapel Hill and the Universidad del Valle in Guatemala.
Analysis
Our analytic approach was informed by Maxwell and Miller’s theory of qualitative analysis 
in which they distinguish between categorizing (or thematic) approaches and connecting (or 
narrative) approaches.18 We drew on this distinction in order to balance our engagement 
with participant’s rich stories while also identifying key themes within each stage of the HIV 
continuum. Our analytic team included one of the interviewers along with researchers from 
the participating universities and community-based organizations that work with study 
populations. We first wrote narrative summaries of each participant’s HIV experiences to 
summarize the process of navigating the HIV continuum of care, capture the meaning of 
these experiences, and describe the context in which they managed life with HIV.19,20 The 
research team discussed and compared the narrative summaries to inform the collaborative 
development of a thematic codebook. The codebook contained both descriptive codes 
derived from the interview guide (e.g., place of diagnosis, place of treatment) and 
interpretive codes derived from themes and ideas from the narrative analysis (e.g., 
discrimination, fear, desire to live).20 Code definitions were collectively written and 
discussed until the team reached consensus. The interviews were then systematically coded 
using the Atlas.ti software (version 7) through an iterative process.21 Following coding, the 
team developed matrices to organize and further reduce the data along the three stages of the 
continuum that we focus on in this paper: diagnosis, linkage, and retention in care.22 These 
matrices also facilitated comparative analysis across the two strata we focus on in this paper: 
year of diagnosis (and study population (MSM vs transgender). Matrices were reviewed by 
the team and key findings were re-contextualized by returning to the narrative summaries.
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Results
We first provide a description of the study population (Table 1) followed by our analysis of 
participants’ experiences with diagnosis, linkage to care and retention. The study population 
provided experiences that cover over 30 years. Average age for MSM was 38 years (range 21 
to 66 years for MSM) and 41 years for transgender women (range 23 to 70). Most MSM had 
completed high school (n=7) or some amount of college (n=4) ; only 2 transgender women 
had some college and 2 had completed secondary school. The majority of all participants 
were single; 2 MSM participants were married or in union. Only 3 MSM and 4 transgender 
women reported living alone. Consistent with findings from our past research with MSM 
and transgender women in Guatemala, most MSM lived with their families or partners while 
transgender women rented rooms in a house or lived with friends.17 While both groups 
mentioned difficulties getting jobs, the majority of MSM had some paid work at the time of 
the interview (n=10) while less than half of the transgender women (n=4) reported having 
paid work. Involvement in sex work, currently or in the past, was common among both 
groups, though more so among transgender women (n=7 MSM, n=9 transgender women). 
All but two participant were engaged in HIV care at the time of the interview, one MSM and 
one transgender woman.
Diagnosis
Across the last 30 years of living with HIV represented in this study, themes related to 
diagnosis varied substantially over time as the social context and availability of services 
have evolved. One noteworthy trend over time was where participants got tested (Table 2). 
Among participants diagnosed prior to 2006, most were diagnosed in public hospitals or 
clinics (n=2 MSM, n=4 transgender women) or private laboratories or clinics (n=3 MSM, 
n=1 transgender woman). Only two participants, both transgender, were diagnosed at non-
governmental organizations (NGO) prior to 2006. In contrast, among those diagnosed since 
2007 there was more testing occurring at NGOs (n=3 MSM, n=2 transgender women) with 
continued use of public hospitals and clinics (n=3 MSM, n=2 transgender). Only 1 MSM 
participant reported getting diagnosed at a private clinic or lab after 2007. Most participants 
diagnosed since 2007 in both NGO and public hospitals reported receiving pre- and post-test 
counseling, which was not true of the earlier diagnoses in hospitals and labs.
Among all participants and time periods, the most commonly identified reason for getting 
tested was being sick, in some cases gravely ill (Table 2). More recently, however, there was 
increased use of voluntary HIV testing as a preventive behavior or in response to perceived 
risk. In the group diagnosed prior to 2006, three MSM participants were diagnosed 
asymptomatically while donating blood or during a check-up for a work physical. However, 
only 1 MSM identified asymptomatic testing motivated by risk perception prior to 2006. 
Three MSM in the more recently diagnosed group were tested asymptomatically. One 46-
year-old gay man diagnosed in 2009 described getting tested as a preventive measure for his 
health because he had seen many of his friends die:
I experienced seeing my friends die of HIV. And I was afraid that I might have it. 
We had potentially shared the same people, we had had sex with the same people…
I saw a friend, and he was very skinny, and I thought, I have it too. So [I] was afraid 
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of getting tested. But I went before I got to that [bad state of health]. I went before 
that and did the test and came out positive. (MSM, age 46, diagnosed 2009)
As reflected in this quotation, many participants expressed feeling fear related to testing. 
While this participant got tested before having symptoms, for many others fear was a driver 
of delayed testing.
There was also a shift over time with regard to who participants were with when they got 
tested. Individuals who got tested because they were very sick were frequently accompanied 
by a family member because they could not physically go alone. In contrast, both MSM and 
transgender participants who got tested as a form of prevention at an NGO were frequently 
with friends. Several participants across both time periods intentionally got tested alone, as 
described by a 46 year-old- transgender woman diagnosed in 1999:
No, with no one, with no one, no because, I don’t trust those women, and I didn’t 
tell anyone afterward either, only I know. Only I know and no one else. I don’t even 
want to tell my mother because she will cry and be worried and, so I don’t tell her, 
just I know…because sometimes, let’s say I tell someone, then that person can go 
and get drunk and talk about it, and say, hey look they have HIV. So it’s better it is 
just me. (transgender woman, age 46, diagnosed 1999)
This quotation reflects how lack of trust within the transgender community in the late 90s 
led to this participant getting tested alone. This lack of trust transcended time and other 
spheres of the participant’s life, leading her to opt for not disclosing her status to anyone. 
Another transgender women, diagnosed in 2008, echoed this sentiment saying that she got 
tested alone fearing that “someone would find out.”
The diagnosis experience was frequently quite traumatic, especially among those who were 
diagnosed in the late 1990s and early 2000s before testing and counseling was widely 
available. Participants described feelings of fear, guilt, anguish, and depression in response 
to their diagnosis. Many of those diagnosed at hospitals or labs before 2006 were unaware 
that HIV test was even being done; some received the news briskly from a doctor or were 
simply handed an envelope with the results. A 39-year-old transgender woman diagnosed in 
the 1980s described how little was known about HIV when she was tested and how little 
infrastructure existed:
It was horrible! We didn’t even know what they were talking about, you know? It 
was a boom in the U.S. It was a boom for the whole world, and we knew nothing. 
Not what was happening, not why it was happening, you know? It was very 
difficult, there weren’t support groups or lectures or pre-test counseling, none of 
that existed. The word HIV didn’t even exist. Imagine, what it sounded like to hear 
them tell you that you had AIDS. (transgender woman, age 39, diagnosed 1986)
The combination of how participants found out their status and the lack of services, or 
knowledge about services, created anxiety and depression for many during the diagnostic 
period.
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Linkage to care
We identified several barriers and facilitators to getting linked to HIV care. The time from 
diagnosis to enrollment ranged from immediate (for those who were diagnosed in hospitals 
with serious health complications related to HIV) to seven years. Barriers to linkage to care 
for those who were not diagnosed when already sick included fear, denial, and lack of 
symptoms.
Overall, linkage was a salient topic for both MSM and transgender women who were 
recently diagnosed. Participants diagnosed with a poor health status were much less likely to 
have a significant lapse between their diagnosis and linkage to care; in these cases, poor 
health status paradoxically acted as a facilitator to HIV care, especially if they were 
diagnosed in a hospital setting. A 44-year-old MSM man diagnosed in 2002, who initially 
refused immediate treatment, was linked into care in under a week because he was 
diagnosed with such severe health problems that he couldn’t walk and was nearly blind. 
However, when his doctor tried to admit him to the hospital, he said “If I’m going to die, I’d 
rather die at home.” After a few days at home, his family took him back to the hospital. This 
example highlights the important role of social support, in this case family support, in timely 
linkage to care.
Aside from the health condition at diagnosis, the other main factors driving delayed linkage 
to care, which transcended time periods, included depression, denial, fear and confusion. 
Depression and denial both created barriers to taking action towards linkage to care. Others 
diagnosed in a healthy state who were not linked into treatment in a timely manner were 
fearful, especially of involuntary disclosure as a part of getting into care and also of the 
treatment itself. A 23-year-old transgender woman diagnosed in 2010, waited nearly three 
years to enter into care after her diagnosis, due to fear. She cited depression, suicidal 
ideation, and fear of involuntary disclosure for delaying her linkage. Three years after her 
diagnosis, she noticed small declines in her health and realized that deteriorating health 
could also could also reveal her status, which pushed her to get into care. Another 
transgender woman who was diagnosed in 2008 had still not been linked to care at the time 
of the interview,
I am afraid [to get into care], because I feel healthy. Also it is obvious that I’m not 
sick and I don’t get sick…I promise, my scars heal in three or four days, but I’m 
afraid of taking a fucking medicine, and ugh, what is it going to do to me, I’m 
going to take medicine that is going to make me sick? I don’t know, I don’t know. 
That is my reaction. (transgender woman, age 31, diagnosed 2008)
This quotation reflects the synergistic influence of fear of the unknown, fear of treatment 
side effects, and some denial (“I don’t get sick”) working together as barriers to care.
While fear of involuntary disclosure was a major barrier to seeking out HIV care, for most 
participants, disclosure led to support for getting into care. A young gay man diagnosed in 
2013 who delayed getting into careand was very adamant that his family not find out about 
his sero-status described disclosing to another HIV-positive friend:
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Sometimes I would think [after my diagnosis], what is happening? What did I do? I 
would see there was no way out. No solution. But finally, I told an old friend of 
mine who is also positive, and she said, ‘look, you have to keep living, we will not 
die of this, we have to live,’ to take this as an opportunity to live….she asked if I 
was taking medicine. No I said, I don’t want to take medicine, she said, you have to 
do for your health, and so your family doesn’t find out, because otherwise you will 
get sick and they will find out. I stopped and thought about it, and then I had to go, 
we had to go, and I went. I went [to start treatment]. (MSM, age 21, diagnosed in 
2013)
Supportive relationships played an important role in linkage to care by helping participants 
see past their fears, appreciate the value of their health, and understand the importance that 
treating HIV can have for their lives. In addition to the importance of support from a friend 
living with HIV, this participant again highlights how fear of poor health being an indicator 
of HIV was a motivator to get into care.
Retention in care
Key determinants of retention in care overlapped with determinants of linkage, including 
supportive relationships and health status. Retention-specific determinants included clinic 
dynamics, economic resources, and stigma and discrimination. Participants who had 
disclosed their HIV status to their families, roommates, friends, or coworkers often received 
support to stay in care and adhere to treatment. Many participants reported that friends who 
were living with HIV gave them advice on where to seek care, what organizations ran good 
support groups, and links to informal support groups. These relationships provided key 
information and resources to support staying in care. Among MSM participants in particular, 
families provided support by cooking for specific dietary requirements, giving rides to 
appointments, and providing care during health crises. These forms of family support 
facilitated retention in care by helping participants to attend their appointments and follow 
their prescribed diets.
While many participants reported emotional support from disclosure, not all experiences 
with disclosure were positive, especially when coupled with disclosure of sexual orientation. 
Among MSM, many described situations where their family did not support or accept their 
sexuality, but would offer instrumental or material support related to their HIV status. For 
example, one 42-year-old gay man who had been homeless when he was diagnosed, moved 
back in with his family after disclosing his HIV status. They did not support him in his 
sexual orientation, however, and told him,
I don’t want any faggots coming to knock on my door looking for you, understand?
…You can live in your world, we respect that is who you are, but no one will come 
to my door saying they want to talk to you, or watch TV with you, none of that. 
(MSM, age 42, diagnosed in 2013)
The isolation of living with his parents and being denied contact with his social world was 
difficult. However, his parents provided critical support related to his HIV. Before moving in 
with them, he walked long distances to his appointments but after moving back home, his 
father drove him at 4 a.m. so that he could be the first one in line for care, which is important 
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given the large number of patients seen at the two main HIV clinics in Guatemala City on a 
daily basis. His parents also made sure that his basic needs were covered, cooked him 
appropriate food, and made sure he was physically comfortable. This challenging dynamic 
of families not accepting or approving of a participant’s sexual orientation or gender 
identity, but giving them support related to their HIV care, was mentioned by several 
participants.
While there were examples of support from family and friends related to HIV, participants 
also described experiencing social isolation and rejection, which could make staying in care 
challenging. A 66-year-old gay man diagnosed in 1998 was thrown out of his house when he 
told his family about his HIV status. They also burned his clothes because they feared 
infection. This family’s fears reflect a combination of HIV stigma and lack of knowledge. 
Another example of social rejection was the experience of a 42-year-old gay man diagnosed 
in 2013. His partner left him when he disclosed his status and his family isolated him, again 
out of fear of infection:
Now they understand the situation of, of what HIV is because I’ve also… I’ve 
opened their minds a bit, because there were very closed minded when I came here 
[to live with them]. They separated my plates, they separated everything, they said, 
‘here is your bathroom, and your apartment, you don’t have to even come 
downstairs.’ They closed off this little world, but now, I’ve talked to them, and little 
by little they’ve been opening up, opening their eyes. (MSM, age 42, diagnosed in 
2013)
This quotation reflects a process of communication and adaptation within families, led by 
the participant, which slowly led to provision of the support that was critical to remaining in 
care.
Having trusting relationships with HIV clinic staff and providers enabled participants to stay 
in treatment and adhere to care and treatment in interesting ways. Care providers included 
not only doctors, but also nurses and other clinical staff. For instance, several participants, 
both MSM and transgender women, discussed feeling comfortable enough with the clinic 
staff to be able to call and change appointments when needed. One MSM participant noted 
that clinic staff trusted his history of adherence, which facilitated communication and 
flexibility with his appointment schedule. This flexibility was important as it allowed 
participants to avoid missing appointments and then fearing negative reactions by clinic 
staff, which could lead to dropping out of care. Participants also described asking to be 
scheduled with doctors they felt treated them well or avoiding those doctors who they didn’t 
have a good relationship with to improve their care experience.
While some participants discussed developing trust with clinic staff, many also described 
experiencing discrimination related to their sexual orientation and/or gender identities in the 
HIV clinics where they received care. Discrimination acted as a barrier to care as by creating 
distrust of providers and making participants fearful of getting care. While there were 
examples of discrimination among both the MSM and transgender women, discrimination 
was more salient for transgender women. Transgender women experienced discrimination 
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by staff who refused to use their female names, an experience described by a 23-year-old 
transgender woman diagnosed in 2010:
“One day I arrived dressed [as a women] and they call me by my name, my legal 
name, and it made me feel bad and it was in front of all the people waiting in the 
hospital. It made me feel bad, but I let it go and I didn’t want to say anything. 
(transgender woman, age 23, diagnosed in 2010)
Only one transgender participant who experienced this type of treatment described 
addressing it with her provider; most reacted as the woman quoted above and did not do 
anything. Another way transgender women experienced discrimination in care settings was 
being stared at, pointed at, and watched by other partients, and clinic staff. These 
experiences undermined transgender women’s trust in the clinics, which could negatively 
impact their retention. Some participants highlighted receiving good treatment and high 
quality HIV care but negative experiences in other health care settings. For example, a 42-
year-old MSM diagnosed in 2013 described seeking care for a foot injury and the doctors 
did not want to touch him because he was a gay man living with HIV. This participant had a 
positive relationship with his HIV doctor to whom he turned to get help accessing the care 
he needed for his foot, highlighting the importance of a good relationship with the primary 
HIV doctor for services beyond HIV.
Another important structural determinant of retention was lack of economic resources and 
job opportunities, especially among transgender women. Lack of economic resources 
impacted retention by limiting access to transportation to get to their appointments. Another 
way limited economic opportunities impacted retention was through food. A 42-year-old 
transgender women explained,
Also, not having a job, partially because there are less possibilities since I’m older. 
But we need to have a good diet, eat your four times a day, if possible, and 
sometimes I can’t do it, because I’m bad economically and I can’t go house to 
house asking because I would be ashamed to ask. But I always try to find 
something [to eat], like a piece of bread. (transgender woman, age 42, diagnosed in 
1984)
Both MSM and transgender women experienced economic marginalization due to their 
gender identities and sexual orientation. Their HIV status further limited employment 
opportunities and exacerbated their lack of financial resources. In a few cases, participants, 
mostly MSM, had jobs doing work related to HIV that were both a source of economic and 
also emotional support. A 25 year-old gay man diagnosed in 2008, described receiving such 
support even when he tried to push people away:
Some of the people I work with currently know my status, and they are the ones 
that most often tell me, hey, take your medicines, don’t stop going to your 
appointments, read about HIV, and more. Sometimes they come up to me and say, 
‘hey are you ok? You don’t look well’ if I’m not doing well I’ll tell them to go 
away and stopping to me and they will say, ‘hey what’s up? Are you ok? Finally I’ll 
tell them I took my medication last night and I’m in a bad mood, and they will say 
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to me, ‘ok we will make sure no one bothers you, if anyone comes looking for you 
we will say you aren’t here.’ (MSM, age 25, diagnosed in 2008)
This participant also discussed being able to ask for time off for appointments, which 
facilitated his ability to get to his appointment.
Discussion
Based on our in-depth qualitative analysis, we described the historical context of HIV testing 
and linkage to care among MSM and transgender women in Guatemala City. We identified 
several important factors that shape experiences with HIV diagnosis, linkage to HIV care, 
and retention and, ultimately, create the context for achieving treatment as prevention (TasP) 
with MSM and transgender women in Guatemala City. Fear, of disclosure, death, and the 
impact of HIV in participant’s lives, weresalient factors affecting all three stages of the HIV 
care continuum.. Fear of the physical and social impacts of HIV had a notably negative 
effect on early testing, acceptance of diagnosis, and enrollment in HIV care. These fears 
were frequently driven and/or exacerbated by the layered stigma and discrimination that 
participants experienced due to their non-normative gender expressions and/or sexual 
orientation. These findings echo previous findings of fear as a barrier to HIV testing MSM 
and transgender women in Guatemala City and highlight the salience of the debilitating 
impact of layered stigma.6,7 As further evidence of the impact of stigma related to sexual 
orientation, in the most recent integrated behavioral and biological survey with MSM in 
Guatemala City, individuals who had not disclosed their sexual orientation to anyone were 
less likely to have been previously tested.23
By obtaining a sample of participants whose diagnoses ranged over three decades, we were 
able to identify shifts in the availability and use of HIV testing services, which appear to be 
contributing to earlier diagnosis. We found that delayed testing, or getting tested in response 
to serious medical complications, was especially common among the participants who were 
diagnosed in the late 1990s and early 2000s. These participants were not “linked to care” as 
they usually required immediate treatment related to HIV and other conditions. In contrast, 
for those who were diagnosed since the mid-2000s, getting into HIV care required more 
effort to enroll in HIV services, including overcoming the aforementioned fears. Paz-Bailey 
et al. found that MSM in the US who were diagnosed the first time they were tested 
experienced delayed linkage,24 highlighting the need to integrate linkage support systems 
into early testing efforts.25 A few participants mentioned benefitting from the support and 
experience of a peer who was also living with HIV, though there was no evidence of any 
programs to help recently diagnosed individuals navigate the psychological, physical and 
logistical challenges of the HIV care system. Earlier diagnosis and immediate linkage to 
care is critical for promoting TasP by getting individuals onto anti-retroviral therapy early. 
While the trend towards early testing we observed in this sample is encouraging, there is a 
clear need to continue improving access to HIV testing and linkage to care among MSM and 
transgender women in Guatemala City.26 Peer navigation models could be effective in 
helping individuals to manage the fear and psychological impact of the diagnosis as well as 
facilitate timely linkage to care.27,28
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We also explored retention in care and found that the salient themes related to retention were 
mostly interpersonal, in particular family, clinic and provider dynamics, and contextual, 
including stigma and discrimination, poverty, and employment. Family support, even when 
the family was not accepting of the participant’s sexual orientation and/or gender identity, 
was critical for many participants to stay in care and take care of their health. This finding 
echoes our previous research on the dual experience of social rejection and social support 
within family networks among MSM and transgender women in Guatemala.17 Strengthening 
the link between clinics and families could be an important way to improve long-term 
retention in care and adherence.29 While having trusted relationships with providers was an 
important facilitator of retention in care, stigma and discrimination related to HIV, sexual 
orientation, and/or gender identity created barriers to staying in care, as has been found in 
other settings.10 There is a need for ongoing sensitization and capacity building with all staff 
and clinical care providers in order to continue improving the overall environment of the 
clinics for these key populations.30
Many participants also discussed their lack of employment and dire economic situation as 
barriers to staying in care and adhering to their treatment regimens. Transgender women 
were especially vulnerable to mistreatment in clinics as well as unemployment and poverty, 
highlighting the need for improved support services to promote holistic wellbeing and the 
opportunity to live productively with HIV. Based on research with MSM and transgender 
women living with HIV in the Dominican Republic, we developed a conceptual model for 
the role of unemployment as a mediator between HIV stigma and HIV outcomes.31 We 
found that MSM and transgender women living with HIV did not have jobs because HIV 
stigma led to them getting fired, not getting hired, and not even applying out of fear of 
disclosure of their HIV results. Participants who were under or unemployed experienced 
mental health problems, extreme poverty, interrupted care and treatment, and changed HIV 
clinics, which can lead to poor HIV outcomes. In contextualizing these potential links, it is 
important to recognize that the trajectories of vulnerability among MSM and transgender 
women, starting with early life stigmatizing and discriminatory experiences related to 
gender, and sexual orientation, may limit work opportunities later in life. Based on our 
findings, we believe this conceptual model applies to the experiences of MSM and 
transgender women living with HIV in Guatemala and highlights the need to address 
employment as a social determinant of HIV outcomes, including retention in care, among 
these key populations.
This study has several limitations. Most of the participants were currently engaged in HIV 
care. While this allowed them to reflect on the process of getting diagnosed and into care, it 
also meant they had effectively overcome the barriers they experienced and may not have 
represented the full range of barriers and challenges. While their experiences may not be 
reflective of all individuals in Guatemala City, we believe the themes they identified are 
important to consider in future programming. Recall may have also been compromised for 
some due to the long time (up to 30 years) since diagnosis.
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Conclusion
Men who have sex with men and transgender women are disproportionately affected by HIV 
in Guatemala City. Despite recent improvements in the documentation of these disparities 
through rigorous HIV surveillance, the response is still lagging. There is an urgent need to 
improve support systems for early testing and linkage to care and to expand employment 
opportunities for MSM and transgender women living with HIV. Across all stages of the 
HIV continuum, layered stigma and discrimination related to HIV, sexual orientation, and 
gender must be addressed to reduce fear and improve access to all stages of care.
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Table 1
Description of the study population of men who have sex with men and transgender women living with HIV in 
Guatemala City
MSM
(n=15)
Transgender women
(n=11)
Average age (range) 38 (21-66) 41 (23-70)
Education
 Primary 2
 Middle school 3 5
 Secondary 7 2
 University 4 2
Civil status
 Married/In union 2
 Single/Divorced 13 11
Currently has paid work 10 4
Has done sex work (past or present) 7 9
Living arrangement
 Alone 3 4
 Lives with others 12 7
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